Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
STEMLINE THRPTS
(NQ:
STML
)
14.75
USD
-0.25 (-1.67%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
16.05
Bid (Size)
14.70 (500)
Ask (Size)
14.72 (200)
Prev. Close
15.00
Today's Range
14.50 - 16.14
52wk Range
10.40 - 17.00
Shares Outstanding
7,675,373
Dividend Yield
N/A
Top News
More News
Stemline Therapeutics Prices $60 Million Public Offering of Common Stock
May 16, 2013
from
GlobeNewswire News Releases
Stemline Therapeutics (STML) files for $50 M offering
May 07, 2013
By Aegis Capital STML’s goal is to maintain and fortify a leadership position in the discovery, acquisition and development of novel oncology therapies that target commercialization of CSC-directed...
Read More
category
Henry McCusker
from
Bio-Wire.Com
More News
Read More
Post-IPO Strength Seen In Stemline Therapeutics
May 02, 2013
category
Bio/Wire
,
STML
from
Bio-Wire.Com
Stemline Therapeutics to Present at the 12th Annual Needham Healthcare Conference on May 1, 2013
April 25, 2013
from
GlobeNewswire News Releases
RegMed Sector, riding the teeter-tooter on the playground
April 08, 2013
category
Henry McCusker
from
Bio-Wire.Com
Stemline Therapeutics, Inc. Announces Presentation of SL-401 Preclinical Efficacy in Multiple Myeloma at the 14th International Myeloma Workshop in Kyoto, Japan
April 08, 2013
from
GlobeNewswire News Releases
Stemline Therapeutics Reports Year-End 2012 Financial Results
April 01, 2013
from
GlobeNewswire News Releases
Stemline Therapeutics to Present at the 25th Annual Roth Conference on March 20, 2013
March 12, 2013
from
GlobeNewswire News Releases
Stemline Therapeutics to Present at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013
February 27, 2013
from
GlobeNewswire News Releases
Stemline Therapeutics to Present at Leerink Swann and Company Global Healthcare Conference
February 12, 2013
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here